![Andrew Harbottle](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Andrew Harbottle
Chief Tech/Sci/R&D Officer at MDNA Life Sciences, Inc.
Profile
Andrew Harbottle is currently the Chief Science Officer at MDNA Life Sciences, Inc. He obtained a doctorate degree from Newcastle University.
Andrew Harbottle active positions
Companies | Position | Start |
---|---|---|
MDNA Life Sciences, Inc.
![]() MDNA Life Sciences, Inc. Medical/Nursing ServicesHealth Services MDNA Life Sciences, Inc. engages in the development of molecular tests based on the mitochondrial genome. It focuses on the development and commercial application of mitochondrial DNA based biomarkers for the early detection of prostate, ovarian and lung cancers, and endometriosis. The company was founded by Mark Birch-Machin, Robert Thayer, and Ryan L. Parr in 2001 and is headquartered in West Palm Beach, FL. | Chief Tech/Sci/R&D Officer | 2014-10-31 |
Training of Andrew Harbottle
Newcastle University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
MDNA Life Sciences, Inc.
![]() MDNA Life Sciences, Inc. Medical/Nursing ServicesHealth Services MDNA Life Sciences, Inc. engages in the development of molecular tests based on the mitochondrial genome. It focuses on the development and commercial application of mitochondrial DNA based biomarkers for the early detection of prostate, ovarian and lung cancers, and endometriosis. The company was founded by Mark Birch-Machin, Robert Thayer, and Ryan L. Parr in 2001 and is headquartered in West Palm Beach, FL. | Health Services |
- Stock Market
- Insiders
- Andrew Harbottle